News + Filings Holdings
|
|
TANG CAPITAL MANAGEMENT LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
ALNYLAM PHARMACEUTICALS, INC.
| ALNY | COM | 0 | -105,000 | 0 | -24,953,250,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
ENANTA PHARMACEUTICALS INC
| ENTA | COM | 0 | -200,000 | 0 | -9,304,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
ALBIREO PHARMA, INC.
| ALBO | COM | 0 | -411,968 | 0 | -8,902,628,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
CONCERT PHARMACEUTICALS, INC.
| CNCE | COM | 0 | -1,150,000 | 0 | -6,716,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
CYTOKINETICS INC
| CYTK | COM NEW | 0 | -110,000 | 0 | -5,040,200,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
BioNTech SE
| BNTX | SPONSORED ADS | 0 | -30,000 | 0 | -4,506,600,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Alibaba Group Holding Ltd
| BABA | SPONSORED ADS | 0 | -50,000 | 0 | -4,404,500,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
iTeos Therapeutics, Inc.
| ITOS | Common | 0 | -216,700 | 0 | -4,232,151,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Orchestra BioMed Holdings, Inc.
| HSAQ | ORD SHS | 0 | -392,500 | 0 | -3,917,150,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Allakos Inc.
| ALLK | Common | 0 | -447,967 | 0 | -3,771,882,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Beam Therapeutics Inc.
| BEAM | Common | 0 | -95,000 | 0 | -3,715,450,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Arcus Biosciences, Inc.
| RCUS | Common | 0 | -147,920 | 0 | -3,058,986,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Legend Biotech Corp
| LEGN | SPONSORED ADS | 0 | -60,000 | 0 | -2,995,200,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
TCR2 THERAPEUTICS INC.
| TCRR | Common | 0 | -2,738,947 | 0 | -2,735,660,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
MoonLake Immunotherapeutics
| MLTX | Common | 0 | -245,714 | 0 | -2,579,997,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
ASLAN Pharmaceuticals Ltd
| ASLN | Common | 0 | -5,364,925 | 0 | -1,931,373,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Metacrine, Inc.
| MTCR | Common | 0 | -4,250,000 | 0 | -1,903,575,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Aldeyra Therapeutics, Inc.
| ALDX | COM | 0 | -272,293 | 0 | -1,895,159,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
CTI BIOPHARMA CORP
| CTIC | Common | 0 | -300,000 | 0 | -1,803,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Tonix Pharmaceuticals Holding Corp.
| TNXP | Common | 0 | -4,500,419 | 0 | -1,754,263,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Blueprint Medicines Corp
| BPMC | COM | 0 | -40,000 | 0 | -1,752,400,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Celldex Therapeutics, Inc.
| CLDX | COMMON | 0 | -21,192 | 0 | -944,527,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Sio Gene Therapies Inc.
| SIOX | COM | 0 | -2,000,000 | 0 | -870,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
TScan Therapeutics, Inc.
| TCRX | Common | 0 | -514,655 | 0 | -797,715,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Olema Pharmaceuticals, Inc.
| OLMA | Common | 0 | -318,926 | 0 | -781,369,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Orchard Therapeutics plc
| ORTX | Common | 0 | -2,000,000 | 0 | -742,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Surface Oncology, Inc.
| SURF | Common | 0 | -429,647 | 0 | -352,311,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
RELMADA THERAPEUTICS, INC.
| RLMD | Common | 0 | -100,000 | 0 | -349,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Gossamer Bio, Inc.
| GOSS | COM | 0 | -100,000 | 0 | -217,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Vincerx Pharma, Inc.
| VINC | Common | 0 | -101,762 | 0 | -103,797,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
REVIVA PHARMACEUTICALS HOLDINGS, INC.
| RVPH | Common | 0 | -24,125 | 0 | -102,531,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Reneo Pharmaceuticals, Inc.
| RPHM | Common | 0 | -30,587 | 0 | -71,268,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|